# PHYSIO R2 — final post-code closure

> **Reviewed exact implementation head:** `f5c99fcd34117e8bb1488e7b654db2f2448797d3`
> **Verdict:** **PASS / COMPLETE_FOR_DECLARED_SCOPE / no new material finding**
> **Method:** one independent read-only delta + affected-cumulative closure of the material finding at `fbf0701`, with original `c6eb295` findings rechecked.
> **Date:** 2026-10-05 Asia/Nicosia.

The final reviewer confirmed that additional rows refresh when either the evidence code or source-availability styling differs from the returned evidence. The fallback conditional → active conditional path for walking aid now renders as active, and inactive transitions use the same comparison. Static and prototype R2 JavaScript are identical.

Both original post-code findings remain closed: walking aid and other additional choices remain selectable only within Proposed Plan additional options, with categorized non-selecting summaries; incomplete restriction entry stays client-side, blocks export and sends only valid completed state. The final delta makes no shared CU-1 or projection change. The reviewer found no new material risk in the affected cumulative scope.

At the reviewed head, focused prototype browser **6/6** and protected Cockpit browser **4/4** passed, including walking-aid availability, deselection, adjunct hierarchy, restriction recovery, R2-B/CU-1 and CY_GESY checks. `git diff --check` passed. This is an implementation-fidelity closure, not Product Owner real-device acceptance, clinical pilot evidence, merge, deployment or production smoke.

**Next:** checkpoint the PASS without code mutation, open a bounded PR with canonical-impact declaration, and run exact applicable PR gates. Merge/deploy remain separate decisions.
